KROS - Keros Therapeutics appoints Jasbir S. Seehra as Chair of board June, 17 2024 04:10 PM Keros Therapeutics Inc. 2024-06-17 16:10:12 ET More on Keros Therapeutics Keros Therapeutics: Potential Beyond KER-050 For Targeting Of Blood Cancers Seeking Alpha’s Quant Rating on Keros Therapeutics Historical earnings data for Keros Therapeutics Financial information for Keros Therapeutics For further details see: Keros Therapeutics appoints Jasbir S. Seehra as Chair of board